Skip to main navigation Skip to search Skip to main content

Assessment of the application for renewal of authorisation of avemix® xg 10 (Endo-1,4-beta-xylanase and endo-1,3 (4)-beta-glucanase) for chickens for fattening

  • EFSA FEEDAP Panel

Research output: Contribution to journalA1: Web of Science-article

Abstract

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of AveMix® XG 10 (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) for chickens for fattening. The applicant has provided evidence that the additive currently in the market complies with the existing conditions of authorisation. There is no new evidence that would lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concludes that the additive remains safe for the target species, consumer and the environment under the authorised conditions of use. Regarding user safety, the additive is not considered to be a dermal or eye irritant but it is a dermal and respiratory sensitiser. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
Original languageEnglish
JournalEFSA Journal
Volume18
Issue number4
Pages (from-to)e06062
Number of pages8
ISSN1831-4732
DOIs
Publication statusPublished - Apr-2020

Keywords

  • 'endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase'
  • AveMix((R))
  • XG 10
  • Zootechnical additive
  • chickens for fattening
  • digestibility enhancer
  • safety

Fingerprint

Dive into the research topics of 'Assessment of the application for renewal of authorisation of avemix® xg 10 (Endo-1,4-beta-xylanase and endo-1,3 (4)-beta-glucanase) for chickens for fattening'. Together they form a unique fingerprint.

Cite this